Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger homeobox protein 3 (ZFHX3) is a large transcription factor characterized by multiple zinc finger motifs and homeodomains. It regulates gene expression by binding to AT-rich motifs in enhancers and promoters, orchestrating diverse biological processes such as neuronal and myogenic differentiation, cell cycle regulation, and suppression of oncogenes. ZFHX3 has key physiological roles in tumor suppression, circadian rhythm regulation (notably in the suprachiasmatic nucleus), and cardiovascular function. Loss or mutation of ZFHX3 is associated with several cancers, cardiovascular diseases (especially atrial fibrillation), neurodevelopmental disorders, and inflammation. ZFHX3 can serve as a biomarker for certain cancer immunotherapies and for prognosis in atrial fibrillation and other disease states[1][2][3][4].
Transcriptional regulation by DNA binding at AT-rich enhancers and promoters[2][1]\nModulation of gene expression related to cell cycle, apoptosis, and differentiation[2]\nSuppression or activation of specific growth-control genes (e.g., alpha-fetoprotein, c-Myb, CDKN1A)[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger homeobox protein 3 (ZFHX3).